Vascular disease continues to be a leading cause of morbidity and mortality worldwide. The SVDx test leverages state-of-the-art technology to provide comprehensive insights into a patient’s ...

Vascular disease continues to be a leading cause of morbidity and mortality worldwide. The SVDx test leverages state-of-the-art technology to provide comprehensive insights into a patient’s ...

MorningStar Laboratories, LLC., (“MSL” or “the Company”), is a leading developer of precision diagnostic tests that address unmet clinical needs, is proud to announce its expansion in the Midwest with ...

IRVINE, Calif., June 19, 2025 (GLOBE NEWSWIRE) -- MorningStar Laboratories, LLC., (“MSL” or “the Company”), a leading developer of precision diagnostic tests that address unmet clinical ...

A new study from UCLA Health has uncovered how inflammation in brain blood vessels exacerbates damage in vascular dementia ...

UCLA researchers found that two proteins doctors use to check for heart damage can also predict cancer years before symptoms ...

IRVINE, Calif., June 11, 2025 (GLOBE NEWSWIRE) -- MorningStar Laboratories, LLC ('MSL” or 'the Company”), a leading developer of precision diagnostic tests that address unmet clinical needs, proudly ...

IRVINE, Calif., June 11, 2025 (GLOBE NEWSWIRE) -- MorningStar Laboratories, LLC (“MSL” or “the Company”), a leading developer of precision diagnostic tests that address unmet clinical ...

IRVINE, Calif., June 11, 2025 (GLOBE NEWSWIRE) -- MorningStar Laboratories, LLC (“MSL” or “the Company”), a leading developer of precision diagnostic tests that address unmet clinical needs, proudly ...